These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37717069)

  • 1. A cleavage rule for selection of increased-fidelity SpCas9 variants with high efficiency and no detectable off-targets.
    Kulcsár PI; Tálas A; Ligeti Z; Tóth E; Rakvács Z; Bartos Z; Krausz SL; Welker Á; Végi VL; Huszár K; Welker E
    Nat Commun; 2023 Sep; 14(1):5746. PubMed ID: 37717069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage.
    Kulcsár PI; Tálas A; Huszár K; Ligeti Z; Tóth E; Weinhardt N; Fodor E; Welker E
    Genome Biol; 2017 Oct; 18(1):190. PubMed ID: 28985763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
    Kleinstiver BP; Pattanayak V; Prew MS; Tsai SQ; Nguyen NT; Zheng Z; Joung JK
    Nature; 2016 Jan; 529(7587):490-5. PubMed ID: 26735016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput analysis of the activities of xCas9, SpCas9-NG and SpCas9 at matched and mismatched target sequences in human cells.
    Kim HK; Lee S; Kim Y; Park J; Min S; Choi JW; Huang TP; Yoon S; Liu DR; Kim HH
    Nat Biomed Eng; 2020 Jan; 4(1):111-124. PubMed ID: 31937939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-depth assessment of the PAM compatibility and editing activities of Cas9 variants.
    Zhang W; Yin J; Zhang-Ding Z; Xin C; Liu M; Wang Y; Ai C; Hu J
    Nucleic Acids Res; 2021 Sep; 49(15):8785-8795. PubMed ID: 34133740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMOOT libraries and phage-induced directed evolution of Cas9 to engineer reduced off-target activity.
    Cerchione D; Loveluck K; Tillotson EL; Harbinski F; DaSilva J; Kelley CP; Keston-Smith E; Fernandez CA; Myer VE; Jayaram H; Steinberg BE
    PLoS One; 2020; 15(4):e0231716. PubMed ID: 32298334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deleting specific residues from the HNH linkers creates a CRISPR-SpCas9 variant with high fidelity and efficiency.
    Wang G; Wang C; Chu T; Wu X; Anderson CM; Huang D; Li J
    J Biotechnol; 2023 May; 368():42-52. PubMed ID: 37116617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the sequence-specific cleavage activity of Cas9 variants.
    Kim N; Kim HK; Lee S; Seo JH; Choi JW; Park J; Min S; Yoon S; Cho SR; Kim HH
    Nat Biotechnol; 2020 Nov; 38(11):1328-1336. PubMed ID: 32514125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered CRISPR/Cas9 enzymes improve discrimination by slowing DNA cleavage to allow release of off-target DNA.
    Liu MS; Gong S; Yu HH; Jung K; Johnson KA; Taylor DW
    Nat Commun; 2020 Jul; 11(1):3576. PubMed ID: 32681021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA targeting specificity of RNA-guided Cas9 nucleases.
    Hsu PD; Scott DA; Weinstein JA; Ran FA; Konermann S; Agarwala V; Li Y; Fine EJ; Wu X; Shalem O; Cradick TJ; Marraffini LA; Bao G; Zhang F
    Nat Biotechnol; 2013 Sep; 31(9):827-32. PubMed ID: 23873081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced proofreading governs CRISPR-Cas9 targeting accuracy.
    Chen JS; Dagdas YS; Kleinstiver BP; Welch MM; Sousa AA; Harrington LB; Sternberg SH; Joung JK; Yildiz A; Doudna JA
    Nature; 2017 Oct; 550(7676):407-410. PubMed ID: 28931002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
    Hu JH; Miller SM; Geurts MH; Tang W; Chen L; Sun N; Zeina CM; Gao X; Rees HA; Lin Z; Liu DR
    Nature; 2018 Apr; 556(7699):57-63. PubMed ID: 29512652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SpCas9-HF1 enhances accuracy of cell cycle-dependent genome editing by increasing HDR efficiency, and by reducing off-target effects and indel rates.
    Matsumoto D; Matsugi E; Kishi K; Inoue Y; Nigorikawa K; Nomura W
    Mol Ther Nucleic Acids; 2024 Mar; 35(1):102124. PubMed ID: 38328481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome Engineering in Rice Using Cas9 Variants that Recognize NG PAM Sequences.
    Hua K; Tao X; Han P; Wang R; Zhu JK
    Mol Plant; 2019 Jul; 12(7):1003-1014. PubMed ID: 30928636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Plant Genome Editing with High-Fidelity xCas9 and Non-canonical PAM-Targeting Cas9-NG.
    Zhong Z; Sretenovic S; Ren Q; Yang L; Bao Y; Qi C; Yuan M; He Y; Liu S; Liu X; Wang J; Huang L; Wang Y; Baby D; Wang D; Zhang T; Qi Y; Zhang Y
    Mol Plant; 2019 Jul; 12(7):1027-1036. PubMed ID: 30928637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the range of CRISPR/Cas9-directed genome editing in soybean.
    He R; Zhang P; Yan Y; Yu C; Jiang L; Zhu Y; Wang D
    aBIOTECH; 2022 Jun; 3(2):89-98. PubMed ID: 36312444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted gene disruption by CRISPR/xCas9 system in Drosophila melanogaster.
    Ni XY; Zhou ZD; Huang J; Qiao X
    Arch Insect Biochem Physiol; 2020 May; 104(1):e21662. PubMed ID: 32027059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered CRISPR-Cas9 nucleases with altered PAM specificities.
    Kleinstiver BP; Prew MS; Tsai SQ; Topkar VV; Nguyen NT; Zheng Z; Gonzales AP; Li Z; Peterson RT; Yeh JR; Aryee MJ; Joung JK
    Nature; 2015 Jul; 523(7561):481-5. PubMed ID: 26098369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfectly matched 20-nucleotide guide RNA sequences enable robust genome editing using high-fidelity SpCas9 nucleases.
    Zhang D; Zhang H; Li T; Chen K; Qiu JL; Gao C
    Genome Biol; 2017 Oct; 18(1):191. PubMed ID: 29020979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the scope of CRISPR/Cas9-mediated genome editing in plants using an xCas9 and Cas9-NG hybrid.
    Niu Q; Wu S; Li Y; Yang X; Liu P; Xu Y; Lang Z
    J Integr Plant Biol; 2020 Apr; 62(4):398-402. PubMed ID: 31702097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.